Aurobindo Pharma Receives Final Approval For Cetirizine Hydrochloride Solution (05-Feb-2010)
Aurobindo Pharma Limited is pleased to announce that it has received the final approval for Cetirizine Hydrochloride Solution 1 mg/mL (OTC) from the US Food & Drug Administration (USFDA). This approval of Cetirizine Hydrochloride Solution is under over-the-counter (OTC) product category.
Cetirizine Hydrochloride Solution 1mg/ml_ is the generic equivalent of McNeil Consumer Healthcare Children''s Zyrtec Oral Solution (Allergy), 1 mg/mL and Children''s Zyrtec Oral Solution (Hives Relief), 1 mg/mL. Cetrizine Hydrochloride Solution is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children above 2 years of age and falls under the Anti-Allergic segment. Other indications include relief from itching due to hives. The product will be launched shortly.
Aurobindo has a total of 111 ANDA approvals (83 Final approvals and 28 Tentative approvals) from USFDA
Top News Today
 Mahindra Satyam, the brand identity of Satyam Computer Services has developed an integrated migration solutions for healthcare payer organizations that would meet the new federal and Health Insurance Portability
 Private sector air carrier, Kingfisher Airlines, has decided to mop-up fresh funds of up to Rs 5,000 crore through issue of various instruments including preference shares, equity shares, Global Depository
 The government is expected to take decision on exportable quantity of cotton this week. The move follows recent lifting of the export ban on the cotton which was imposed earlier this year to restrict spiraling
|
Live Market Discussions With Site Visitors
|
|
|